This study investigated signal transduction pathways activated by stimulation of I1-imidazoline receptors in PC12 cells. The study found that stimulation of these receptors with moxonidine:
1) Increased the activity of PKC beta II and redistributed the atypical PKC zeta isoform into cell membranes. It did not affect the novel PKC theta isoform.
2) Increased the proportion of active, phosphorylated forms of ERK-1 and ERK-2, as well as increasing JNK enzymatic activity.
3) The effects of moxonidine on ERK activation were blocked by an I1 receptor antagonist and a PC-PLC inhibitor, suggesting PC-PLC mediates I
This study examined the role of IKKα kinase activity in regulating NF-κB target gene expression using gene expression profiling. Rescuing wild-type IKKα in IKKα knockout mouse embryonic fibroblasts globally restored expression of canonical NF-κB targets. Surprisingly, rescuing a kinase-dead IKKα mutant also rescued expression of approximately 28% of these genes, both independently of and dependently on TNFα stimulation. Thus, IKKα regulates NF-κB target gene expression through both kinase-dependent and independent mechanisms in both stimulus-dependent and independent manners. Five distinct classes of IKKα/NF-κB-dependent genes were identified.
10 nazir ahmad malla and mudasir bashir 215 plant protein kinases in signal ...Dheeraj Vasu
ABSTRACT: A protein kinase is a enzyme that modifies other proteins by adding phosphate groups to them. This results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. Cells can interact to environmental fluctuations by transduction of extracellular signals, to produce intracellular responses. Membrane-impermeable signal molecules are recognized by receptors, which are localized on the plasma membrane of the cell. Binding of a ligand can result in the stimulation of an intrinsic enzymatic activity of its receptor or the modulation of a transducing protein. This review discusses the various protein kinases and their role in plants.
Phosphorylation of serine 526 in the activation loop of MEKK3 is required for its kinase activity and ability to activate downstream signaling pathways. Mutation of serine 526 to alanine abolished MEKK3 activity, while mutation to aspartic or glutamic acid created constitutively active mutants. Serine 526 is autophosphorylated and its phosphorylation is regulated by protein phosphatase 2A and its association with 14-3-3 proteins, which prevents dephosphorylation. Phosphorylation of endogenous MEKK3 on serine 526 occurs in response to osmotic stress.
This document presents information on the diacylglycerol pathway. It discusses how diacylglycerol (DAG) is an essential secondary messenger in mammalian cells and its levels are regulated by diacylglycerol kinase, diacylglycerol lipase, and diacylglycerol acyltransferase. DAG plays an important role in activating protein kinase C, which controls various cellular processes. DAG is also involved in regulating insulin secretion by increasing calcium ion concentration and stimulating glucose uptake in pancreatic beta cells. Finally, DAG functions as a source for prostaglandins and helps secrete thyroid-releasing hormone and oxytocin.
Regulated gene expression is required for adaptation, differentiation, and development in organisms. In prokaryotes, genes involved in metabolic pathways are often arranged in operons, where a single regulatory region controls multiple structural genes. The lac operon in E. coli regulates genes for lactose metabolism. In the absence of lactose, the lac repressor binds the operator region and prevents transcription. When lactose is present, it binds the repressor and induces a conformational change that reduces its affinity for DNA, allowing transcription. This is an example of negative regulation through repression and derepression.
Protein kinases are enzymes that phosphorylate other proteins and cause functional changes in target proteins. There are over 500 types of protein kinases in genomes that can modify about 30% of proteins. Protein kinase A, C, and G are three important protein kinases that are regulated by different mechanisms and have various functions in different cell types. Protein kinases play critical roles in many cellular processes and their dysregulation can lead to diseases like cancer.
This document discusses checkpoints in the cell cycle and mutations. It describes the four phases of the cell cycle and two major checkpoints - G1/S and G2/M. Progression through the cell cycle is controlled by cyclins and cyclin-dependent kinases (Cdks). Mutations can occur spontaneously or be induced by mutagens like radiation and chemicals. They can cause changes in DNA sequences and structures. Checkpoint genes and tumor suppressor genes normally prevent mutations from causing cancer, but their mutation allows uncontrolled cell growth.
This document provides an overview of the diacylglycerol (DAG) signaling pathway. It defines DAG as a lipid second messenger formed through the hydrolysis of phosphatidylinositol 4,5-bisphosphate. DAG activates downstream effectors including protein kinase C (PKC), protein kinase D, RasGRPs, chimaerins, and Munc13s to regulate various cellular processes. DAG signaling is terminated through phosphorylation by DAG kinases into phosphatidic acid. The document reviews the roles and activation of different PKC isoforms and provides examples of cellular processes regulated by PKC and DAG signaling, such as gene expression, proliferation, and vascular responses to stress.
This study examined the role of IKKα kinase activity in regulating NF-κB target gene expression using gene expression profiling. Rescuing wild-type IKKα in IKKα knockout mouse embryonic fibroblasts globally restored expression of canonical NF-κB targets. Surprisingly, rescuing a kinase-dead IKKα mutant also rescued expression of approximately 28% of these genes, both independently of and dependently on TNFα stimulation. Thus, IKKα regulates NF-κB target gene expression through both kinase-dependent and independent mechanisms in both stimulus-dependent and independent manners. Five distinct classes of IKKα/NF-κB-dependent genes were identified.
10 nazir ahmad malla and mudasir bashir 215 plant protein kinases in signal ...Dheeraj Vasu
ABSTRACT: A protein kinase is a enzyme that modifies other proteins by adding phosphate groups to them. This results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. Cells can interact to environmental fluctuations by transduction of extracellular signals, to produce intracellular responses. Membrane-impermeable signal molecules are recognized by receptors, which are localized on the plasma membrane of the cell. Binding of a ligand can result in the stimulation of an intrinsic enzymatic activity of its receptor or the modulation of a transducing protein. This review discusses the various protein kinases and their role in plants.
Phosphorylation of serine 526 in the activation loop of MEKK3 is required for its kinase activity and ability to activate downstream signaling pathways. Mutation of serine 526 to alanine abolished MEKK3 activity, while mutation to aspartic or glutamic acid created constitutively active mutants. Serine 526 is autophosphorylated and its phosphorylation is regulated by protein phosphatase 2A and its association with 14-3-3 proteins, which prevents dephosphorylation. Phosphorylation of endogenous MEKK3 on serine 526 occurs in response to osmotic stress.
This document presents information on the diacylglycerol pathway. It discusses how diacylglycerol (DAG) is an essential secondary messenger in mammalian cells and its levels are regulated by diacylglycerol kinase, diacylglycerol lipase, and diacylglycerol acyltransferase. DAG plays an important role in activating protein kinase C, which controls various cellular processes. DAG is also involved in regulating insulin secretion by increasing calcium ion concentration and stimulating glucose uptake in pancreatic beta cells. Finally, DAG functions as a source for prostaglandins and helps secrete thyroid-releasing hormone and oxytocin.
Regulated gene expression is required for adaptation, differentiation, and development in organisms. In prokaryotes, genes involved in metabolic pathways are often arranged in operons, where a single regulatory region controls multiple structural genes. The lac operon in E. coli regulates genes for lactose metabolism. In the absence of lactose, the lac repressor binds the operator region and prevents transcription. When lactose is present, it binds the repressor and induces a conformational change that reduces its affinity for DNA, allowing transcription. This is an example of negative regulation through repression and derepression.
Protein kinases are enzymes that phosphorylate other proteins and cause functional changes in target proteins. There are over 500 types of protein kinases in genomes that can modify about 30% of proteins. Protein kinase A, C, and G are three important protein kinases that are regulated by different mechanisms and have various functions in different cell types. Protein kinases play critical roles in many cellular processes and their dysregulation can lead to diseases like cancer.
This document discusses checkpoints in the cell cycle and mutations. It describes the four phases of the cell cycle and two major checkpoints - G1/S and G2/M. Progression through the cell cycle is controlled by cyclins and cyclin-dependent kinases (Cdks). Mutations can occur spontaneously or be induced by mutagens like radiation and chemicals. They can cause changes in DNA sequences and structures. Checkpoint genes and tumor suppressor genes normally prevent mutations from causing cancer, but their mutation allows uncontrolled cell growth.
This document provides an overview of the diacylglycerol (DAG) signaling pathway. It defines DAG as a lipid second messenger formed through the hydrolysis of phosphatidylinositol 4,5-bisphosphate. DAG activates downstream effectors including protein kinase C (PKC), protein kinase D, RasGRPs, chimaerins, and Munc13s to regulate various cellular processes. DAG signaling is terminated through phosphorylation by DAG kinases into phosphatidic acid. The document reviews the roles and activation of different PKC isoforms and provides examples of cellular processes regulated by PKC and DAG signaling, such as gene expression, proliferation, and vascular responses to stress.
Epidermal Growth Factor use in Diabetic Foot UlcersG H PRABHU
The document discusses epidermal growth factor (EGF) and EGF receptor (EGFR). It describes how Stanley Cohen discovered EGF in the 1950s while working with Rita Levi-Montalcini. It provides details on the structure and function of EGF, which is a 6045 Da protein, and EGFR. EGFR is a receptor tyrosine kinase that is activated upon binding of EGF or other ligands, leading to dimerization and autophosphorylation of tyrosine residues which propagate intracellular signaling cascades that influence cell proliferation, survival and other processes.
NRF2 plays a dual role in cancer - it can function as both a tumor suppressor and promote cancer progression. Under normal conditions, NRF2 activates antioxidant genes to protect against oxidative stress and carcinogens. However, in cancer cells NRF2 is often hyperactivated and allows cells to evade chemotherapy by increasing antioxidant defenses and drug efflux pumps. Brusatol is a potential inhibitor of the NRF2 pathway that could sensitize cancer cells to chemotherapy by reducing NRF2 levels and antioxidant gene expression. More research is still needed to better understand the context-specific roles of NRF2 and develop NRF2 inhibitors for safe clinical use in cancer treatment.
This document provides information about protein synthesis and the role of genes in controlling cellular activities. It discusses how DNA contains instructions in genes that are used to produce mRNA through transcription. The mRNA then directs protein synthesis through translation with the help of tRNA. Proteins fold into complex 3D structures determined by amino acid sequences that allow them to perform specific functions. Issues can arise if errors occur during protein production.
Targeting unfolded protein response in neurodegenerationShahan Ullah
Neurodegenerative diseases like Alzheimer's, Parkinson's, and prion diseases are characterized by the misfolding and aggregation of proteins in the brain. This document discusses how the unfolded protein response (UPR) pathway is activated in prion disease as misfolded prion proteins accumulate. The UPR pathway involves three branches - PERK, IRE1, and ATF6 - that work to reduce protein synthesis and promote protein folding. In prion disease, persistent phosphorylation of the PERK target eIF2α leads to repression of global protein translation. Overexpressing the phosphatase GADD34 or knocking down prion proteins in mouse models prevented eIF2α phosphorylation and neurodegeneration by restoring protein synthesis. In
The NF-κB/Rel family consists of signal-responsive transcription factors that are activated by signals like cytokines and bacterial LPS. They exist as inactive complexes in the cytoplasm bound to inhibitory IκB proteins. Upon stimulation, IκB is degraded and NF-κB dimers translocate to the nucleus to activate target genes involved in immune, inflammatory, and stress responses. The family includes proteins containing Rel homology domains that form homo- and heterodimers and are regulated by two main signaling pathways, one dependent on IKKβ and the other on IKKα and NIK.
This PPT has described how to produce soluble anf high amount of recombinant protein in E.coli host. This PPT has mentioned different expression vectors, different E.coli Expression host strain and other strategies for getting high expression of desired gene.
Nrf2 Transcription Factor- Nuclear Factor- Erythroid 2 related factor)PHARMA IQ EDUCATION
1. Nrf2- transcription factor
2. Reactive Oxygen Species
3. Free Radicals
4. Antioxidant Defence Mechanism
5. Function of Nrf2 receptor
6. Protein structural domain of Nrf2
7. Protein structural domain of Keap1
8. Physiological Role pf Nrf2
9.
THANK YOU
Molecular biology revision-Part 3 (Regulation of genes expression and Recombi...Namrata Chhabra
1) Gene expression in eukaryotes is regulated through various mechanisms including chromatin remodeling, enhancers and repressors, locus control regions, gene amplification, gene rearrangement, alternative RNA processing, class switching, and mRNA stability.
2) Key differences in prokaryotic and eukaryotic gene expression include larger eukaryotic genomes, different cell types requiring gene regulation, lack of operons, chromatin structure, and uncoupling of transcription and translation.
3) The lac operon in E. coli is regulated through negative control in the absence of lactose, double negative control in the presence of only lactose, and absence of positive control in the presence of both glucose and lactose.
Gene expression in bacteria and bacteriophagesVinod Pawar
1. The document discusses gene regulation in bacteria, focusing on the lac operon in E. coli. which controls lactose metabolism. 2. The lac operon contains 3 genes - lacZ, lacY, lacA - that are regulated together. When lactose is present, it is broken down into allolactose, which binds the lac repressor and prevents it from blocking transcription of the operon. 3. Experiments by Jacob and Monod identified mutations affecting regulation, including mutations in the operator or repressor gene that result in constitutive expression of the lac genes.
Tissue specificity of phenyl proponoids prakashsp13
The document discusses phenylpropanoids (PPs), a class of plant secondary metabolites that are produced in response to stress. PPs have antioxidant and anti-inflammatory properties. They are found in many foods and medicines. The document outlines several specific PPs (resveratrol, chlorogenic acid, caffeic acid) and their roles in protecting plants from pathogens and modulating human cell and molecular processes. PPs have potential applications as antioxidants, anticancer agents, and treatments for other diseases due to these protective properties.
This presentation on "Cell Cycle regulation" takes you to the cell cycle describing the stages and checkpoints involved providing some of the evidences of cell cycle regulation. Then we will move to cyclins and cyclin dependent kinases and the mechanism they follow.
This journey in regulation of cell cycle will take a halt after a general discussion of positive and negative cell cycle regulators.
Thankyou.
The document summarizes key aspects of the cell cycle, including its four main phases (G1, S, G2, and M) and control mechanisms. It describes the roles of cyclins and cyclin-dependent kinases (CDKs) in driving progression between phases, as well as CDK inhibitors that act as brakes. Critical cell cycle checkpoints ensure DNA integrity before progression. Deregulation of cyclins, CDKs, and their inhibitors can lead to uncontrolled cell division and cancer.
Li, Lisanti, Puszkin - Purification and molecular characterization of NP185Shengwen Calvin Li, PhD
This study further characterized the neuronal protein NP185/AP3 through several experiments:
1) Microsequence analysis of purified native NP185 from bovine brain yielded five peptide fragments that matched sequences of mouse F1-20 and rat AP180 proteins.
2) Recombinant NP185/AP3 purified using genetic methods facilitated the reconstruction of clathrin cages in an established assay.
3) Deletion mutagenesis mapped the epitopes of two monoclonal antibodies that recognize bovine NP185 to a 60 amino acid region of recombinant murine NP185/AP3.
4) Recombinant NP185/AP3 was phosphorylated by purified casein kinase II in vitro.
Second messengers are intracellular signaling molecules that are released within cells in response to extracellular first messengers like hormones and neurotransmitters. They amplify and propagate intracellular signals. Examples include cyclic AMP (cAMP), cyclic GMP (cGMP), inositol trisphosphate, and calcium. cAMP and cGMP are produced from ATP and GTP by adenylate and guanylate cyclases, respectively. They activate downstream effector proteins like protein kinase A and G. This leads to phosphorylation of various target proteins and physiological responses like metabolism, gene expression, cell survival, proliferation and apoptosis. The document discusses the mechanisms, targets, functions and therapeutic applications of cAMP and cGMP second messenger systems in detail.
1. The document discusses research into how inhibition of TXNRD or SOD1 can overcome resistance to β-lapachone that is mediated by NRF2. Stable cell lines were generated for experiments using lentiviral transduction.
2. Western blot and fluorescence techniques were used to analyze protein expression and localization. Nuclear isolation was also utilized. Results showed that overexpression of KEAP1 or NRF2 led to resistance to β-lapachone. Silencing NRF2 reduced this resistance.
3. Depletion of catalase did not affect β-lapachone sensitivity, but inhibition of TXNRD with auranofin increased DNA damage and cell death in response to β-lap
This document summarizes regulation of gene expression in bacteria and eukaryotes. It discusses how bacteria regulate genes through the operon model, including repressible and inducible operons like the trp and lac operons. In eukaryotes, it describes various levels of gene expression regulation, from chromatin structure and histone/DNA modifications, to transcription factors and epigenetic inheritance. Gene expression can be regulated at the stages of transcription, RNA processing, transport, translation and degradation.
Assignment on Secondary messengers and intracellular signalingDeepak Kumar
Assignment on Secondary messengers: cyclic AMP, cyclic GMP, calcium ion, inositol 1,4,5- trisphosphate, (IP3), NO, and diacylglycerol. Detailed study of following intracellular signaling pathways: cyclic AMP signaling pathway, mitogen-activated protein kinase (MAPK) signaling, Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway.
The document discusses gene regulation in cells. It explains that not all genes are expressed at all times, and that gene expression is regulated at multiple levels, including transcription, post-transcription, translation, and post-translation. It provides examples of constitutive genes that are continually expressed and inducible genes that are only expressed when needed. Key concepts like operons, promoters, repressors, and chromatin remodeling are introduced to illustrate gene regulation mechanisms in prokaryotes and eukaryotes.
This document reports on a study examining how carbon monoxide (CO) induces heme oxygenase-1 (HO-1) expression and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum (ER) stress. The key findings are:
1) CO activates the transcription factor Nrf2 through phosphorylation of the protein kinase R-like ER kinase (PERK), leading to increased HO-1 expression.
2) CO-induced PERK activation results in phosphorylation of eukaryotic translation initiation factor 2α and expression of activating transcription factor 4.
3) CO prevents ER stress-induced expression of X-box binding protein 1 and cleavage of activating transcription factor 6.
4) CO inhibits
Molecular approaches study the structure and function of genes at a molecular level using methods of molecular biology and genetics. They can identify simple and complex effects of genes on growth regulation and study the interaction of genes and the environment related to crop growth regulation. Key techniques include PCR, recombinant DNA technology, genetic transformation, RNA interference, microarrays, and molecular markers.
Translational Control of Autism Spectrum Disorders in Eif4ebp2 knockout Mouse...Rey Christian Pacis
1) NKCC1, a chloride importer implicated in autism, is upregulated in Eif4ebp2 knockout mice compared to wildtype. This may cause excitatory-inhibitory imbalances linked to autism.
2) Phosphorylated forms of eIF4E, mTOR, and ERK are also upregulated in knockouts, and may be important in translational control of NKCC1. Total eIF4E is downregulated.
3) Total levels of mTOR, ERK, and Akt, as well as phosphorylated Akt, show trends of change but are not significantly different between knockout and wildtype mice.
Glypican and Biglycan in the Nuclei of Neurons and Glioma CellsYu Liang
This document describes a study that found glypican and biglycan, two proteoglycans, localized to the nuclei of neurons and glioma cells. The researchers identified nuclear localization signals in the amino acid sequences of both proteoglycans. They demonstrated that these signals were functional by showing nuclear localization of beta-galactosidase fusion proteins containing the sequences. Nuclear localization was reduced or abolished when the basic amino acids in the signals were mutated. Dynamic changes in glypican immunoreactivity in the nucleus of glioma cells were also observed during cell division and different phases of the cell cycle. The findings suggest glypican and biglycan may be involved in regulating cell division and survival by participating in nuclear processes in
Epidermal Growth Factor use in Diabetic Foot UlcersG H PRABHU
The document discusses epidermal growth factor (EGF) and EGF receptor (EGFR). It describes how Stanley Cohen discovered EGF in the 1950s while working with Rita Levi-Montalcini. It provides details on the structure and function of EGF, which is a 6045 Da protein, and EGFR. EGFR is a receptor tyrosine kinase that is activated upon binding of EGF or other ligands, leading to dimerization and autophosphorylation of tyrosine residues which propagate intracellular signaling cascades that influence cell proliferation, survival and other processes.
NRF2 plays a dual role in cancer - it can function as both a tumor suppressor and promote cancer progression. Under normal conditions, NRF2 activates antioxidant genes to protect against oxidative stress and carcinogens. However, in cancer cells NRF2 is often hyperactivated and allows cells to evade chemotherapy by increasing antioxidant defenses and drug efflux pumps. Brusatol is a potential inhibitor of the NRF2 pathway that could sensitize cancer cells to chemotherapy by reducing NRF2 levels and antioxidant gene expression. More research is still needed to better understand the context-specific roles of NRF2 and develop NRF2 inhibitors for safe clinical use in cancer treatment.
This document provides information about protein synthesis and the role of genes in controlling cellular activities. It discusses how DNA contains instructions in genes that are used to produce mRNA through transcription. The mRNA then directs protein synthesis through translation with the help of tRNA. Proteins fold into complex 3D structures determined by amino acid sequences that allow them to perform specific functions. Issues can arise if errors occur during protein production.
Targeting unfolded protein response in neurodegenerationShahan Ullah
Neurodegenerative diseases like Alzheimer's, Parkinson's, and prion diseases are characterized by the misfolding and aggregation of proteins in the brain. This document discusses how the unfolded protein response (UPR) pathway is activated in prion disease as misfolded prion proteins accumulate. The UPR pathway involves three branches - PERK, IRE1, and ATF6 - that work to reduce protein synthesis and promote protein folding. In prion disease, persistent phosphorylation of the PERK target eIF2α leads to repression of global protein translation. Overexpressing the phosphatase GADD34 or knocking down prion proteins in mouse models prevented eIF2α phosphorylation and neurodegeneration by restoring protein synthesis. In
The NF-κB/Rel family consists of signal-responsive transcription factors that are activated by signals like cytokines and bacterial LPS. They exist as inactive complexes in the cytoplasm bound to inhibitory IκB proteins. Upon stimulation, IκB is degraded and NF-κB dimers translocate to the nucleus to activate target genes involved in immune, inflammatory, and stress responses. The family includes proteins containing Rel homology domains that form homo- and heterodimers and are regulated by two main signaling pathways, one dependent on IKKβ and the other on IKKα and NIK.
This PPT has described how to produce soluble anf high amount of recombinant protein in E.coli host. This PPT has mentioned different expression vectors, different E.coli Expression host strain and other strategies for getting high expression of desired gene.
Nrf2 Transcription Factor- Nuclear Factor- Erythroid 2 related factor)PHARMA IQ EDUCATION
1. Nrf2- transcription factor
2. Reactive Oxygen Species
3. Free Radicals
4. Antioxidant Defence Mechanism
5. Function of Nrf2 receptor
6. Protein structural domain of Nrf2
7. Protein structural domain of Keap1
8. Physiological Role pf Nrf2
9.
THANK YOU
Molecular biology revision-Part 3 (Regulation of genes expression and Recombi...Namrata Chhabra
1) Gene expression in eukaryotes is regulated through various mechanisms including chromatin remodeling, enhancers and repressors, locus control regions, gene amplification, gene rearrangement, alternative RNA processing, class switching, and mRNA stability.
2) Key differences in prokaryotic and eukaryotic gene expression include larger eukaryotic genomes, different cell types requiring gene regulation, lack of operons, chromatin structure, and uncoupling of transcription and translation.
3) The lac operon in E. coli is regulated through negative control in the absence of lactose, double negative control in the presence of only lactose, and absence of positive control in the presence of both glucose and lactose.
Gene expression in bacteria and bacteriophagesVinod Pawar
1. The document discusses gene regulation in bacteria, focusing on the lac operon in E. coli. which controls lactose metabolism. 2. The lac operon contains 3 genes - lacZ, lacY, lacA - that are regulated together. When lactose is present, it is broken down into allolactose, which binds the lac repressor and prevents it from blocking transcription of the operon. 3. Experiments by Jacob and Monod identified mutations affecting regulation, including mutations in the operator or repressor gene that result in constitutive expression of the lac genes.
Tissue specificity of phenyl proponoids prakashsp13
The document discusses phenylpropanoids (PPs), a class of plant secondary metabolites that are produced in response to stress. PPs have antioxidant and anti-inflammatory properties. They are found in many foods and medicines. The document outlines several specific PPs (resveratrol, chlorogenic acid, caffeic acid) and their roles in protecting plants from pathogens and modulating human cell and molecular processes. PPs have potential applications as antioxidants, anticancer agents, and treatments for other diseases due to these protective properties.
This presentation on "Cell Cycle regulation" takes you to the cell cycle describing the stages and checkpoints involved providing some of the evidences of cell cycle regulation. Then we will move to cyclins and cyclin dependent kinases and the mechanism they follow.
This journey in regulation of cell cycle will take a halt after a general discussion of positive and negative cell cycle regulators.
Thankyou.
The document summarizes key aspects of the cell cycle, including its four main phases (G1, S, G2, and M) and control mechanisms. It describes the roles of cyclins and cyclin-dependent kinases (CDKs) in driving progression between phases, as well as CDK inhibitors that act as brakes. Critical cell cycle checkpoints ensure DNA integrity before progression. Deregulation of cyclins, CDKs, and their inhibitors can lead to uncontrolled cell division and cancer.
Li, Lisanti, Puszkin - Purification and molecular characterization of NP185Shengwen Calvin Li, PhD
This study further characterized the neuronal protein NP185/AP3 through several experiments:
1) Microsequence analysis of purified native NP185 from bovine brain yielded five peptide fragments that matched sequences of mouse F1-20 and rat AP180 proteins.
2) Recombinant NP185/AP3 purified using genetic methods facilitated the reconstruction of clathrin cages in an established assay.
3) Deletion mutagenesis mapped the epitopes of two monoclonal antibodies that recognize bovine NP185 to a 60 amino acid region of recombinant murine NP185/AP3.
4) Recombinant NP185/AP3 was phosphorylated by purified casein kinase II in vitro.
Second messengers are intracellular signaling molecules that are released within cells in response to extracellular first messengers like hormones and neurotransmitters. They amplify and propagate intracellular signals. Examples include cyclic AMP (cAMP), cyclic GMP (cGMP), inositol trisphosphate, and calcium. cAMP and cGMP are produced from ATP and GTP by adenylate and guanylate cyclases, respectively. They activate downstream effector proteins like protein kinase A and G. This leads to phosphorylation of various target proteins and physiological responses like metabolism, gene expression, cell survival, proliferation and apoptosis. The document discusses the mechanisms, targets, functions and therapeutic applications of cAMP and cGMP second messenger systems in detail.
1. The document discusses research into how inhibition of TXNRD or SOD1 can overcome resistance to β-lapachone that is mediated by NRF2. Stable cell lines were generated for experiments using lentiviral transduction.
2. Western blot and fluorescence techniques were used to analyze protein expression and localization. Nuclear isolation was also utilized. Results showed that overexpression of KEAP1 or NRF2 led to resistance to β-lapachone. Silencing NRF2 reduced this resistance.
3. Depletion of catalase did not affect β-lapachone sensitivity, but inhibition of TXNRD with auranofin increased DNA damage and cell death in response to β-lap
This document summarizes regulation of gene expression in bacteria and eukaryotes. It discusses how bacteria regulate genes through the operon model, including repressible and inducible operons like the trp and lac operons. In eukaryotes, it describes various levels of gene expression regulation, from chromatin structure and histone/DNA modifications, to transcription factors and epigenetic inheritance. Gene expression can be regulated at the stages of transcription, RNA processing, transport, translation and degradation.
Assignment on Secondary messengers and intracellular signalingDeepak Kumar
Assignment on Secondary messengers: cyclic AMP, cyclic GMP, calcium ion, inositol 1,4,5- trisphosphate, (IP3), NO, and diacylglycerol. Detailed study of following intracellular signaling pathways: cyclic AMP signaling pathway, mitogen-activated protein kinase (MAPK) signaling, Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway.
The document discusses gene regulation in cells. It explains that not all genes are expressed at all times, and that gene expression is regulated at multiple levels, including transcription, post-transcription, translation, and post-translation. It provides examples of constitutive genes that are continually expressed and inducible genes that are only expressed when needed. Key concepts like operons, promoters, repressors, and chromatin remodeling are introduced to illustrate gene regulation mechanisms in prokaryotes and eukaryotes.
This document reports on a study examining how carbon monoxide (CO) induces heme oxygenase-1 (HO-1) expression and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum (ER) stress. The key findings are:
1) CO activates the transcription factor Nrf2 through phosphorylation of the protein kinase R-like ER kinase (PERK), leading to increased HO-1 expression.
2) CO-induced PERK activation results in phosphorylation of eukaryotic translation initiation factor 2α and expression of activating transcription factor 4.
3) CO prevents ER stress-induced expression of X-box binding protein 1 and cleavage of activating transcription factor 6.
4) CO inhibits
Molecular approaches study the structure and function of genes at a molecular level using methods of molecular biology and genetics. They can identify simple and complex effects of genes on growth regulation and study the interaction of genes and the environment related to crop growth regulation. Key techniques include PCR, recombinant DNA technology, genetic transformation, RNA interference, microarrays, and molecular markers.
Translational Control of Autism Spectrum Disorders in Eif4ebp2 knockout Mouse...Rey Christian Pacis
1) NKCC1, a chloride importer implicated in autism, is upregulated in Eif4ebp2 knockout mice compared to wildtype. This may cause excitatory-inhibitory imbalances linked to autism.
2) Phosphorylated forms of eIF4E, mTOR, and ERK are also upregulated in knockouts, and may be important in translational control of NKCC1. Total eIF4E is downregulated.
3) Total levels of mTOR, ERK, and Akt, as well as phosphorylated Akt, show trends of change but are not significantly different between knockout and wildtype mice.
Glypican and Biglycan in the Nuclei of Neurons and Glioma CellsYu Liang
This document describes a study that found glypican and biglycan, two proteoglycans, localized to the nuclei of neurons and glioma cells. The researchers identified nuclear localization signals in the amino acid sequences of both proteoglycans. They demonstrated that these signals were functional by showing nuclear localization of beta-galactosidase fusion proteins containing the sequences. Nuclear localization was reduced or abolished when the basic amino acids in the signals were mutated. Dynamic changes in glypican immunoreactivity in the nucleus of glioma cells were also observed during cell division and different phases of the cell cycle. The findings suggest glypican and biglycan may be involved in regulating cell division and survival by participating in nuclear processes in
Direct conversion of neurons to fibroblastssyed shafiq
The document summarizes a research article that was published in Nature in 2010. The study found that fibroblasts could be directly converted into functional neurons by infecting the cells with viruses containing five transcription factor genes (Ascl1, Brn2, Myt1l, Zic1, and Olig2). The resulting induced neuronal (iN) cells displayed neuronal morphology, membrane properties, and ability to form functional synapses similar to primary neurons. Further experiments showed that Ascl1 alone or Ascl1 combined with Brn2 and Myt1l were able to generate iN cells, demonstrating the key factors required for direct neuronal conversion.
Treatment of mucopolysaccharidosis type IIIB (MPS IIIB) with enzyme replacement therapy has been hindered by the inadequate intracellular uptake of recombinantly produced alpha-N-acetylglucosaminidase (NAGLU). The authors generated an improved form of NAGLU by fusing it to insulin-like growth factor II (IGF-II), which binds to the mannose-6-phosphate receptor. They expressed and purified the NAGLU-IGF-II fusion protein from Chinese hamster ovary cells. Testing in MPS IIIB fibroblasts showed the fusion protein was readily taken up via receptor-mediated endocytosis and reduced glycosaminoglycan storage, supporting its potential as a therapeutic candidate for M
This document discusses the role of the guanine nucleotide exchange factor C3G in neuronal differentiation. It finds that C3G protein levels increase when human neuroblastoma cells are induced to differentiate through serum starvation or treatment with forskolin or nerve growth factor. Overexpression of C3G stimulates neurite growth and increases responsiveness to differentiation signals, in a process dependent on C3G's catalytic domain and the functions of Rap1 and Cdc42. Knockdown of C3G inhibits forskolin- and nerve growth factor-induced differentiation and enhances cell death from serum starvation. C3G phosphorylation and localization to the Golgi are increased by forskolin and nerve growth factor treatment, and C3G
This document summarizes research examining the effects of elevated cyclic AMP (cAMP) levels on expression of the chemokine receptor CXCR4 in human hematopoietic progenitor cells. The study finds that increased cAMP, through activation of protein kinase C ζ (PKCζ), leads to higher CXCR4 expression on the cell surface. This enhanced CXCR4 expression results in greater migration, adhesion, survival and homing of progenitor cells. The cAMP/PKCζ pathway interacts with TNFα signaling and converges on CXCR4 expression and secretion of matrix metalloproteinases.
Na f activates map ks and induces apoptosis in odontoblast-likeGanesh Murthi
The study examined the effects of sodium fluoride (NaF) on odontoblast-like MDPC-23 cells. The researchers found that NaF exposure induced apoptosis in a dose-dependent manner through several markers. NaF activated the mitogen-activated protein kinases (MAPKs) JNK and p38, and induced two peaks in ERK phosphorylation. Inhibition of JNK suppressed NaF-induced apoptosis, while inhibition of p38 and ERK had lesser effects, suggesting NaF-induced apoptosis depends primarily on JNK signaling.
This document discusses phospholipase C (PLC) and its role in neutrophil degranulation and T cell cytotoxicity. PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers, diacylglycerol and inositol 1,4,5-trisphosphate. PLC signaling is required for lytic granule polarization and effective T cell killing through T cell antigen receptor activation. Neutrophil degranulation involves increases in calcium and PLC production of phosphatidylinositol, which is essential for granule exocytosis. Different intracellular signaling pathways regulate the release of primary, secondary, and tertiary granules from neutroph
- A single episomal plasmid containing Oct4, Sox2, KLF4, L-Myc driven by a hybrid CAG promoter can reprogram human fibroblasts into induced pluripotent stem cells (iPSCs).
- The inclusion of 5 small molecules that enhance reprogramming results in the appearance of proto-colonies by 7 days and mature colonies by 21 days under low oxygen conditions.
- The iPSCs express pluripotency markers, can differentiate into neurons and cardiomyocytes, and grow robustly in a new xeno-free media. Further work will examine residual vector presence and gene expression profiles.
This document summarizes various cellular signaling pathways. It discusses how receptors can be linked to enzymatic activities like protein kinases and guanylyl cyclases. It then describes several key intracellular signaling pathways, including the cyclic AMP pathway, cyclic GMP pathway, phospholipid and calcium signaling, PI3 kinase/Akt pathway, and MAP kinase pathway. Each of these pathways transmit signals from cell surface receptors to intracellular targets and regulate processes like gene expression, metabolism, cell growth and differentiation.
This study examined whether contractile activity in cardiomyocytes regulates inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production via focal adhesion kinase (FAK)-dependent signaling. The researchers treated spontaneously contracting neonatal rat ventricular myocytes with inhibitors of contraction and found they reduced iNOS expression and NO production by inhibiting FAK and AKT phosphorylation. Inhibiting FAK or PI3K also eliminated contraction-induced iNOS expression. Knockdown of FAK reduced AKT phosphorylation and iNOS expression, whereas overexpression of constitutively active FAK or AKT reversed the inhibitory effect of contraction inhibitors. Thus, contraction induces iNOS expression and NO production via a FAK-PI3K-AK
This study investigated the effects of an extract from the cyanophyta Aphanizomenon flos-aquae (AFAe) on human natural killer (NK) cells in vitro. The study found that AFAe directly activated NK cells by inducing expression of CD69 and CD25 activation markers. AFAe also modulated the chemokine receptor profile on NK cells. The low-molecular weight fraction (<5,000) of AFAe was responsible for the most robust NK cell activation, suggesting novel activating compounds. This study helps explain previous findings that ingestion of A. flos-aquae in vivo results in transient reduction of peripheral NK cells, suggesting increased NK cell trafficking into tissues.
This document describes a study that investigated the effects of an extract from the cyanobacteria Aphanizomenon flos-aquae (AFAe) on human natural killer (NK) cells in vitro. The key findings were:
1) AFAe directly activated NK cells, as shown by increased expression of the activation markers CD69 and CD25 on CD3-CD56+ NK cells after 18 hours of exposure.
2) The low-molecular-weight fraction (<5,000 Da) of AFAe induced the strongest NK cell activation, suggesting novel activating compounds.
3) NK cell activation by AFAe required the presence of other immune cells such as monocytes, as
This document summarizes an evaluation seminar on cell signaling and signal transduction pathways presented by Mrutyunjay B Bellad of the Department of Pharmacology at H.S.K. College of Pharmacy in Bagalkot. The seminar covered various topics related to cell signaling including introduction, types of cell signaling, signal molecules and their actions, signaling through different receptor types, second messengers, G-protein coupled receptors, and signal transduction pathways. References included standard pharmacology textbooks.
The document discusses second messenger systems. It describes how second messengers relay signals from cell surface receptors to target molecules inside the cell. Some key points discussed include:
- Earl Sutherland discovered cyclic AMP (cAMP) as the second messenger for epinephrine and won the Nobel Prize for this work.
- Common second messenger systems include those using cAMP, cGMP, phosphatidylinositol, and tyrosine kinases as secondary messengers.
- G proteins act as transducers between receptors and effectors and are important drug targets.
- cAMP and cGMP have several downstream targets including protein kinases that phosphorylate other proteins and regulate various cellular processes.
1) The study examined the role of Rho kinase in T cell activation and immune responses.
2) Inhibition of Rho kinase attenuated T cell proliferation, cytokine gene expression, actin polymerization, and aggregation of T cell receptors.
3) Treatment with a Rho kinase inhibitor prolonged survival of allogeneic heart transplants in mice and diminished cytokine mRNA expression in the transplants.
4) Rho kinase promotes structural rearrangements in T cells that are critical for T cell signaling and activation during cellular immune responses.
1) The study investigated the effects of gasdermin D on pyroptosis in a mouse model of sepsis-induced acute kidney injury.
2) The results showed that gasdermin D expression was increased in mice with sepsis-induced acute kidney injury and promoted inflammation and pyroptosis in kidney cells.
3) Downregulating gasdermin D decreased inflammation and pyroptosis, and the NLRP3 inflammasome was identified as an important target of gasdermin D in mediating inflammation during sepsis-induced acute kidney injury.
Research Symposium Poster (Spring - April 2014)William Parker
This study aimed to assess the anti-inflammatory potential of 5,6-EET-EA. Researchers isolated splenocytes from mice and stimulated them with LPS to induce inflammation. They then treated the splenocytes with 5,6-EET-EA or anandamide (AEA) and used flow cytometry to detect levels of inflammatory cytokines IL-6 and TNF-α. The results showed that 5,6-EET-EA decreased IL-6 levels at certain concentrations, similar to the effects of AEA. This suggests that 5,6-EET-EA has anti-inflammatory properties by reducing the levels of pro-inflammatory cytokines. More research is needed to confirm these anti-inflammatory effects, including
The forth lecture about the "Cell".
Here, I am discussing the several signaling pathways.....It is highly dependent on the 3rd lecture; Receptors.
Enjoy :)
Human, Eukaryotic And Vitro Associations Of Murine Sec...Rachel Davis
The document describes experiments to study the effects of vitamin D receptor (VDR) binding to vitamin D response elements (VDREs). Reporter plasmids containing wildtype or mutant VDREs upstream of firefly luciferase were constructed. These plasmids were transfected into HEK293T cells to assess VDR binding and activation of luciferase expression in response to vitamin D treatment.
Similar to The I1 Imidazoline Receptor In Pc12 Pheochromocytoma Cells (20)
The document discusses the recovered memory debate that emerged in the 1980s regarding memories of traumatic events like childhood sexual abuse that were recovered, often in psychotherapy. Some argue these recovered memories are essential to healing, while others argue many recovered memories are distorted or false. The debate examines different perspectives on recovered memories and mechanisms for forgetting traumatic memories like repression and dissociation. It provides examples of cases involving recovered memories that were later corroborated or found to be false.
The document discusses the history and conceptual development of the unconscious. It describes how the concept originated in ancient times and was explored by philosophers like Augustine, Descartes, and Leibniz. It evolved from being seen as a hidden intellect to a mechanical information processing system without true intellect. During the Romantic period, artists emphasized emotions and the individual unconscious mind as a vast realm more capable than consciousness.
The document discusses three major discoveries in psychology:
1. The realization that the brain, not the heart, is the seat of consciousness. Ancient Egyptians believed the heart housed consciousness, but by 1550 BCE some texts acknowledged a role for the brain. It took until the Greeks for this view to be more widely accepted.
2. The development of introspection as a tool for exploring the contents of consciousness. Wilhelm Wundt established the first psychology laboratory in 1879, pioneering the experimental study of the mind through introspection.
3. The emergence of behaviorism as a dominant force in psychology in the early 20th century. John Watson argued psychology should focus on observable behavior rather than internal mental states. Behavior
Conceptualizations Of Major Depressive Disorder (Melancholia) Throughout HistoryDMFishman
This document provides a historical overview of conceptualizations of major depressive disorder (MDD) from ancient times to the present. It describes accounts of depression-like symptoms in ancient Egyptian and biblical texts from around 1500 BCE. It then discusses conceptualizations from Classical Greece, including Hippocrates' description of "melancholia" and accounts of Marcus Tullius Cicero exhibiting MDD symptoms. The document outlines a shift during the Middle Ages in Western Europe towards supernatural explanations for mental illness, while the Byzantine and Islamic worlds preserved classical understandings. It traces evolving understandings over time.
THE EFFECTS OF OPIOID AND BENZODIAZEPINE WEANING ON COGNITIVE ABILITY IN THE ...DMFishman
The study presented here has several important, take-home messages. First, based on the results of this study, withdrawal from opioid and/or benzodiazepine therapy does not result in a measurable change in neurocognitive functioning measured by DS or DSST. Second, a relationship of Pain Intensity to level of functionality has been shown. This is well known, and its finding here reinforces the validity of the methods used herein. Third, there is confirmation that mood greatly effects functioning both physically – as indicated by the BDI/PDI relationship alluded to by the correlational analyses, and psychologically – as borne out by the Δ BDI/ Δ DSST relationship found in both the correlational and hierarchical linear regression analyses. Again, the relationship of mood to functionality, like that of pain intensity to functionality, is well established and its presence in these results reinforces the validity of the methods used. Fourth, changes in mood were found to be the most significant predictor of changes in DSST Scaled score. Fifth, Interdisciplinary treatment of chronic pain provides measurable benefit to all individuals regardless of pre-treatment medication status.
The document discusses treatment strategies for cocaine abuse. It covers the epidemiology of cocaine use and patterns of use such as bingeing. It also discusses clinical manifestations of cocaine intoxication and multiple drug use. The treatment section covers psychotherapy approaches, pharmacotherapies that have been found ineffective such as antidepressants, and potential pharmacotherapies including disulfiram, modafinil, topiramate, and baclofen. Alternative treatments discussed include acupuncture and herbal remedies.
Comparison Of Drug Tx & Psycotherapy in the treatment of DepressionDMFishman
This document discusses and compares pharmacotherapy (medication) and psychotherapy in the treatment of depression. It outlines the diagnostic criteria for major depressive disorder and dysthymia. It then discusses the epidemiology and clinical course of depression before comparing different treatment approaches. Pharmacotherapies discussed include SSRIs, TCAs, and MAOIs. Psychotherapies discussed include cognitive-behavioral therapy and interpersonal therapy.
HCL Notes and Domino License Cost Reduction in the World of DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
TrustArc Webinar - 2024 Global Privacy SurveyTrustArc
How does your privacy program stack up against your peers? What challenges are privacy teams tackling and prioritizing in 2024?
In the fifth annual Global Privacy Benchmarks Survey, we asked over 1,800 global privacy professionals and business executives to share their perspectives on the current state of privacy inside and outside of their organizations. This year’s report focused on emerging areas of importance for privacy and compliance professionals, including considerations and implications of Artificial Intelligence (AI) technologies, building brand trust, and different approaches for achieving higher privacy competence scores.
See how organizational priorities and strategic approaches to data security and privacy are evolving around the globe.
This webinar will review:
- The top 10 privacy insights from the fifth annual Global Privacy Benchmarks Survey
- The top challenges for privacy leaders, practitioners, and organizations in 2024
- Key themes to consider in developing and maintaining your privacy program
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
UiPath Test Automation using UiPath Test Suite series, part 5DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 5. In this session, we will cover CI/CD with devops.
Topics covered:
CI/CD with in UiPath
End-to-end overview of CI/CD pipeline with Azure devops
Speaker:
Lyndsey Byblow, Test Suite Sales Engineer @ UiPath, Inc.
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/building-and-scaling-ai-applications-with-the-nx-ai-manager-a-presentation-from-network-optix/
Robin van Emden, Senior Director of Data Science at Network Optix, presents the “Building and Scaling AI Applications with the Nx AI Manager,” tutorial at the May 2024 Embedded Vision Summit.
In this presentation, van Emden covers the basics of scaling edge AI solutions using the Nx tool kit. He emphasizes the process of developing AI models and deploying them globally. He also showcases the conversion of AI models and the creation of effective edge AI pipelines, with a focus on pre-processing, model conversion, selecting the appropriate inference engine for the target hardware and post-processing.
van Emden shows how Nx can simplify the developer’s life and facilitate a rapid transition from concept to production-ready applications.He provides valuable insights into developing scalable and efficient edge AI solutions, with a strong focus on practical implementation.
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024Neo4j
Neha Bajwa, Vice President of Product Marketing, Neo4j
Join us as we explore breakthrough innovations enabled by interconnected data and AI. Discover firsthand how organizations use relationships in data to uncover contextual insights and solve our most pressing challenges – from optimizing supply chains, detecting fraud, and improving customer experiences to accelerating drug discoveries.
Building Production Ready Search Pipelines with Spark and MilvusZilliz
Spark is the widely used ETL tool for processing, indexing and ingesting data to serving stack for search. Milvus is the production-ready open-source vector database. In this talk we will show how to use Spark to process unstructured data to extract vector representations, and push the vectors to Milvus vector database for search serving.
Communications Mining Series - Zero to Hero - Session 1DianaGray10
This session provides introduction to UiPath Communication Mining, importance and platform overview. You will acquire a good understand of the phases in Communication Mining as we go over the platform with you. Topics covered:
• Communication Mining Overview
• Why is it important?
• How can it help today’s business and the benefits
• Phases in Communication Mining
• Demo on Platform overview
• Q/A
GraphRAG for Life Science to increase LLM accuracyTomaz Bratanic
GraphRAG for life science domain, where you retriever information from biomedical knowledge graphs using LLMs to increase the accuracy and performance of generated answers
Goodbye Windows 11: Make Way for Nitrux Linux 3.5.0!SOFTTECHHUB
As the digital landscape continually evolves, operating systems play a critical role in shaping user experiences and productivity. The launch of Nitrux Linux 3.5.0 marks a significant milestone, offering a robust alternative to traditional systems such as Windows 11. This article delves into the essence of Nitrux Linux 3.5.0, exploring its unique features, advantages, and how it stands as a compelling choice for both casual users and tech enthusiasts.
Threats to mobile devices are more prevalent and increasing in scope and complexity. Users of mobile devices desire to take full advantage of the features
available on those devices, but many of the features provide convenience and capability but sacrifice security. This best practices guide outlines steps the users can take to better protect personal devices and information.
Best 20 SEO Techniques To Improve Website Visibility In SERPPixlogix Infotech
Boost your website's visibility with proven SEO techniques! Our latest blog dives into essential strategies to enhance your online presence, increase traffic, and rank higher on search engines. From keyword optimization to quality content creation, learn how to make your site stand out in the crowded digital landscape. Discover actionable tips and expert insights to elevate your SEO game.
AI 101: An Introduction to the Basics and Impact of Artificial IntelligenceIndexBug
Imagine a world where machines not only perform tasks but also learn, adapt, and make decisions. This is the promise of Artificial Intelligence (AI), a technology that's not just enhancing our lives but revolutionizing entire industries.
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
The I1 Imidazoline Receptor In Pc12 Pheochromocytoma Cells
1. Journal of Neurochemistry, 2001, 79, 931±940
The I1-imidazoline receptor in PC12 pheochromocytoma cells
activates protein kinases C, extracellular signal-regulated kinase
(ERK) and c-jun N-terminal kinase (JNK)
Lincoln Edwards,* Daniel Fishman,* Peleg Horowitz,* Nicole Bourbon,² Mark Kester² and
Paul Ernsberger*
*Departments of Nutrition, Medicine, Pharmacology, and Neuroscience, Case Western Reserve University School of Medicine,
Cleveland, Ohio, USA
²Department of Pharmacology, Pennsylvania State University, Hershey, Pennsylvania, USA
Abstract and JNK followed similar time courses with peaks at 90 min.
We sought to further elucidate signal transduction pathways The action of moxonidine on ERK activation was blocked by
for the I1-imidazoline receptor in PC12 cells by testing the I1-receptor antagonist efaroxan and by D609, an inhibitor
involvement of protein kinase C (PKC) isoforms (bII, 1, z), of phosphatidylcholine-selective phospholipase C (PC-PLC),
and the mitogen-activated protein kinases (MAPK) ERK and previously implicated as the initial event in I1-receptor
JNK. Stimulation of I1-imidazoline receptor with moxonidine signaling. Inhibition or depletion of PKC blocked activation of
increased enzymatic activity of the classical bII isoform in ERK by moxonidine. Two-day treatment of PC12 cells with the
membranes by about 75% and redistributed the atypical I1/a2-agonist clonidine increased cell number by up to 50% in a
isoform into membranes (40% increase in membrane-bound dose related manner. These data suggest that ERK and JNK,
activity), but the novel isoform of PKC was unaffected. along with PKC, are signaling components of the I1-receptor
Moxonidine and clonidine also increased by greater than pathway, and that this receptor may play a role in cell growth.
two-fold the proportion of ERK-1 and ERK-2 in the phos- Keywords: arachidonic acid metabolism, imidazoline, PC12
phorylated active form. In addition, JNK enzymatic activity cells, pheochromocytoma, phospholipases C, receptors.
was increased by exposure to moxonidine. Activation of ERK J. Neurochem. (2001) 79, 931±940.
The existence of a novel imidazoline receptor was ®rst 2000). The encoded protein contains motifs commonly
proposed to account for differential responses to imidazoline associated with cytokine receptors, including leucine-rich
and phenylethylamine a2-adrenergic agonists (Bousquet et al. repeats and serine-rich regions. When the gene is expressed
1984). Subsequently, binding sites speci®c for imidazolines in Chinese hamster ovary (CHO) cells, high-af®nity
were characterized (Ernsberger et al. 1987). It is now binding sites for imidazolines are induced that show
accepted that there are at least two subtypes of imidazoline nanomolar af®nity for clonidine and moxonidine. Functional
receptors, the I1- and I2-subtypes, and possibly a third I3-
subtype (Eglen et al. 1998). The I1-subtypes are character- Resubmitted manuscript received September 5, 2001; accepted
ized by a high af®nity for a group of agents which act in the September 6, 2001.
brainstem to lower blood pressure, including clonidine, Address correspondence and reprint requests to Dr Paul Ernsberger,
rilmenidine and moxonidine (Ernsberger et al. 1995, 1997; Department of Nutrition, Case Western Reserve University School of
Medicine, Cleveland, OH 44106±4906, USA.
Regunathan and Reis 1996). The I2-subtype shows lower E-mail: pre@po.cwru.edu
af®nity for these antihypertensives with a central nervous Abbreviations used: DAG, diacylglycerides; DMSO, dimethyl
system site of action but higher af®nity for other imidazo- sulfoxide; ERK, extracellular signal-regulated kinase; JNK, c-jun
lines and guanidines, and represents a novel recognition site N-terminal kinase; MAPK, mitogen-activated protein kinases; MTS,
on mitochondrial monoamine oxidase (Limon-Boulez et al. [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium] inner salt; NGF, nerve growth factor; PC12
1996). cells, PC12 pheochromocytoma cell line; PC-PLC, phosphatidyl-
A gene encoding an imidazoline binding protein has choline-selective phospholipase C; PKC, protein kinase C; SDS±
been cloned from a human brain cDNA library (Piletz et al. PAGE, sodium dodecyl sulfate±polyacrylamide gel electrophoresis.
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940 931
2. 932 L. Edwards et al.
I1-imidazoline receptors have been identi®ed in neural and that are divided into three classes, namely the extracellular
epithelial cells, including the rostral ventrolateral medulla regulated protein kinase (ERK), c-jun kinase or JNK (also
oblongata (RVLM) region which mediates sympatholytic known as stress-activated protein kinase or SAPK) and the
actions of imidazoline agonists (Ernsberger and Haxhiu p38 family. Activated MAPKs phosphorylate several sub-
1997; Ernsberger et al. 1997), in the eye where they regulate strates in PC12 cells including various transcription factors
ocular pressure (Campbell and Potter 1994), and in the (Cowley et al. 1994). In the present study, we sought to
kidney where they promote urinary sodium excretion determine whether activation of the I1-imidazoline receptor
(Smyth and Penner 1999). Many ligands active at imidazo- by moxonidine leads to activation of one or more PKC
line receptors also bind to a2-adrenergic receptors. There- isoforms or MAPK species, and further whether an increase
fore, functional studies are typically carried out with prior in cellular proliferation might therefore result from stimula-
blockade of a2-adrenergic receptors. Cellular responses to tion of I1-imidazoline receptors.
I1-imidazoline receptor activation, such as effects on
proliferation, have not been described previously.
The predominant cellular model for investigation of Materials and methods
I1-imidazoline receptor signaling pathways has been PC12 Materials
pheochromocytoma cells. These adrenal tumor cells express RPMI medium and horse serum were obtained from GIBCO
I1-imidazoline receptors but lack a2-adrenergic receptors, as (Gaithersburg, MD, USA). Fetal bovine serum, rat tail collagen and
shown by radioligand binding as well as molecular approaches anti-ERK af®nity puri®ed antibodies were obtained from Upstate
(Separovic et al. 1996). Stimulation of the I1-imidazoline Biotechnology (Lake Placid, NY, USA). Moxonidine was kindly
receptor in PC12 cells with the agonist moxonidine leads to provided by Kali-Chemie (Hannover, Germany). Efaroxan and
activation of phosphatidylcholine selective phospholipase C clonidine were purchased from Research Biochemicals Inter-
(PC-PLC) (Separovic et al. 1996, 1997; Ernsberger 1999). national (Natick, MA, USA). The enzyme inhibitors D609 and
H-7 were purchased from Biomol (Plymouth Meeting, PA).
Activation of PC-PLC is characteristic of the signaling
nPKC1, nPKCz, cPKCb11 and JNK goat polyclonal af®nity
pathways coupled to certain cytokine receptors, including
puri®ed antibodies were obtained from Santa Cruz Biotechnology
some of the interleukins receptors (Cobb et al. 1996; Ho (Santa Cruz, CA, USA). Anti-active ERK antibody and donkey
et al. 1994), and also mediates some of the actions of anti-rabbit horseradish peroxidase antibody were purchased from
thromboxanes in astrocytes (Kobayashi et al. 2000). Activa- Promega (Madison, WI, USA). Nerve growth factor (NGF) was
tion of PC-PLC by imidazoline agonists results in increased obtained from Austral Biologicals (San Ramon, CA, USA). Protein
formation of the second messenger diacylglyceride (DAG) assay reagents and the colorimetric PKC assay kit were obtained
from phosphatidylcholine, and the release of phospho- from Pierce (Rockford, IL, USA). All other chemicals were from
choline. These effects can be blocked by both efaroxan, an Sigma Chemical Co. (St Louis, MO, USA) or Fisher (Pittsburgh,
I1-imidazoline receptor antagonist, and by D609, an inhibi- PA, USA) and were of analytical grade.
tor of PC-PLC. Cell signaling steps subsequent to the PC12 cell culture
accumulation of DAG have not been characterized for PC12 cells were cultured as previously reported (Separovic et al.
I1-imidazoline receptor signaling, but DAG commonly 1996). Brie¯y, PC12 cells were grown on 75 cm2 ¯asks coated with
activates several isoforms of PKC. rat tail collagen at 5% CO2 in RPMI 1640 supplemented with 10%
At least 11 isoforms comprise the PKC family (Liu and (v/v) heat-inactivated horse serum, 5% (v/v) fetal bovine serum
Heckman 1998) and these differ according to structure, (FBS), 100 U/mL penicillin, and 100 mg/mL streptomycin (com-
substrate speci®city, cofactor requirement and subcellular plete medium). Cells were subcultured at a plating density of 1 : 6
localization. The PKC isoforms can be classi®ed as classi- once per week and medium was refreshed every two days. Because
previous studies showed that the response to I1-imidazoline
cal, novel and atypical. The classical PKC isoforms (cPKC,
receptor stimulation was enhanced following differentiation of
a, b1, b11, g) are calcium-dependent and activated by DAG
PC12 cells with NGF, for most experiments PC12 cells were
derived from phosphatidylinositol or phosphatidylcholine. treated with NGF (50 ng/mL) in RPMI 1640 medium supplemented
The novel PKC isoforms (nPKC, d, 1, h, u) are also with 1% FBS for 2 days in order to initiate neuronal differentiation.
sensitive to DAG but are calcium independent owing to the
absence of a calcium binding domain. Finally, the atypical Preparation of cell fractions for assay of PKC activity
PKC isoforms (aPKC, i, l, z) are insensitive to DAG or PC12 cells were pre-incubated in RPMI 1640 medium with 10 ng/
mL NGF for 30 min. Cells were then exposed to the following
calcium and may be activated by other cellular signals.
treatments for 10 min: 1.0 mm moxonidine, or 200 nm phorbol-12-
Because I1-imidazoline receptors trigger the accumulation
myristate-13-acetate (PMA), or 0.02% DMSO as vehicle control.
of DAG, we hypothesized that classical and novel PKC All treatments were made up in RPMI medium supplemented with
isoforms might be activated by imidazoline agonists. 10 ng/mL NGF. After treatment, cells were washed with ice-cold
Possible downstream targets for PKC in PC12 cells are RPMI containing 5 mm EGTA, and then removed from the ¯ask by
the family of mitogen-activated protein kinases (MAPKs) scraping. All subsequent steps were carried out at 48C, and each
(Cowley et al. 1994). MAPKs are intracellular mediators ¯ask of cells was processed separately. Cells were pelleted by
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
3. I1-Imidazoline, PKC and MAPK 933
centrifugation at 2000 g for 5 min at 48C. Cell pellets were Tris-HCl pH 7.4,10 mm MgCl2, 2 mm ATP, 0.1 mm CaCl2,
homogenized with a polytron (Tekmar Tissumizer; setting 6 for 0.002% Triton X-100 detergent, and 0.2 mg/mL phosphatidyl-l-
30 s) in 1.0 mL of homogenization buffer containing Tris-HCl, serine. Negative controls were treated identically, but contained
pH 7.4, 50 mm NaF, 0.2 mm Na3VO4, 2.1 mm EDTA, 6.0 mm 10 mL of Tris-HCl buffer at pH 7.4 containing 50% glycerol in
2-mercaptoethanol, 2 mm EGTA, and a cocktail of protease the place of cell fraction. Antibodies and agarose were included in
inhibitors (0.06 mg/mL anti-pain-HCl, 0.01 mg/mL bestatin, the negative controls. The assay mixture also contained 200 nm
0.02 mg/mL chymostatin, 0.06 mg/mL E-64 {N-[N-(l-3-trans- phorbol myristate acetate, except for assays of preactivated PKC
carboxirane-2-carbonyl-l-leucyl]agmatine}, 0.01 mg/mL leupeptin, where this was omitted. After the incubation, a 20 mL aliquot was
0.01 mg/mL pepstatin, 0.06 mg/mL phosphoramidon, 0.4 mg/mL applied to a ferrite af®nity ®lter (Toomik et al. 1993) and washed
pefabloc, and 0.01 mg/mL aprotinin). The homogenate was with three times by vacuum ®ltration with 250 mL of wash buffer,
centrifuged at 106 000 g for 1 h. The resulting supernatant was consisting of 0.5 m NaCl and 0.1 m sodium acetate at pH 5.0.
retained as the cytosolic fraction. Membrane fractions were Phosphopeptide was eluted with 15% formic acid. Absorbance of
obtained by homogenizing the particulate fraction (setting 6 for the eluate was measured at 570 nm in a Rainbow plate reader with
30 s) in 1.5 mL of solublization buffer (homogenization buffer rhodamine-chromagranin as standard. Protein was assayed by the
containing 1% Triton X-100), bath sonication on ice for 15 min, bicinchoninic acid method (Smith et al. 1985). A signi®cant
mixing by slow rotation for 30 min, and then centrifugation at increase in the phosphorylation of rhodamine-chromagranin
15 000 g for 10 min. The resulting supernatant was kept as the substrate, relative to blanks containing buffer and immunocomplex
membrane fraction. alone, was found for each of the three immunoprecipitated PKC
isoforms.
Immunoprecipitation and assay of PKC activity
Immunoprecipitation was carried out on the cytosolic and mem- Assay of ERK activation
brane fractions as previously described (Mandal et al. 1997). Differentiated PC12 cells in 75 cm2 culture ¯asks were treated with
Aliquots of each fraction (15 mL containing 2±5 mg of protein) various doses of moxonidine (0.1 nm21 mm) or clonidine (100 nm)
were treated with 10 mL of the appropriate isozyme speci®c for 0±180 min. In some experiments, cells were pretreated with
antibody (cPKCb11, nPKC1, aPKCz) then incubated with mixing inhibitors (efaroxan, D609 or H-7) or vehicle (0.1 mm acetic acid
for 18 h at 48C. The immunoprecipitates were captured by adding in RPMI) alone for 10 min before the addition of moxonidine. In
25 mL of agarose conjugated to donkey anti-rabbit secondary other experiments, cells were pretreated with 200 nm phorbol
antibodies to each sample, followed by overnight incubation. myristate acetate for 20 h to deplete PKC. After treatment, cells
Precipitates were isolated by centrifugation at 2000 g for 5 min, were washed with ice-cold calcium-free Hank's buffer, removed
washed twice by resuspension and centrifugation with homo- from the ¯ask by scraping, and then collected by centrifugation.
genization buffer and ®nally resuspended in 100 mL of Tris-HCl Cells were subsequently homogenized in lysis buffer (1% Triton
buffer at pH 7.4 containing 50% glycerol. X-100, 0.5% NP-40, 150 mm NaCl, 10 mm Tris pH 7.4, 1 mm
The ef®ciency of immunoprecipitation was determined by Western EDTA, 1 mm EGTA pH 8.0, 0.2 mm sodium ortho-vanadate,
blot analysis of the supernatant and immunoprecipitated fractions. 0.2 mm PMSF, and protease inhibitor cocktail (Boehringer
The immunoprecipitating antibody was used as the primary anti- Mannheim GmbH, Mannheim, Germany) with a polytron (Tecmar
body for western blot analysis. Following immunoprecipitation of Tissuemizer, 15 s at setting 60) followed by centrifugation
either cytosol or membrane fractions with the cPKCb11 antibody, (16 000 g, 48C) for 10 min. Equal amounts of protein (20 mg)
the supernatants contained immunoreactivity for nPKC1 and from the resulting supernatants were subjected to SDS±PAGE on a
aPKCz, but cPKCb11 could not be detected. Similar results were 10% gel and proteins were electrophoretically transferred to a
obtained following immunoprecipitation of cytosol and membrane nitrocellulose membrane for immunodetection with anti-Active
fractions with nPKC1 and aPKCz antibodies. Thus, the ef®ciency MAPK and anti-MAPK antibodies. with a polytron (Tecmar
of immunoprecipitation by each PKC isozyme antibody approached Tissuemizer, 15 s at setting 6) followed by centrifugation at
100%, within the limits of detection of western blot methods. 97 000 g at 48C for 1 h. Aliquots (10 mg protein as assayed by
Immunoprecipitated PKC activity in both membrane and the bicinchoninic acid method) from the resulting supernatants
cytosolic fractions were assayed using a Pierce PKC Colorimetric were subjected to SDS±PAGE on a 10% acrylamide gel and
Assay Kit employing the eight-well strip format. Dye-coupled proteins were electrophoretically transferred to a nitrocellulose
chromagranin (Lissamine Rhodamine B at the N-terminal) was membrane for immunodetection with anti-active ERK and
used as the substrate because this chromaf®n granule protein is an anti-ERK antibodies.
endogenous PKC substrate in PC12 cells. The assay was carried out A dual antibody method was used to quantitate activation of
according to the manufacturer's instructions with two exceptions. ERK as the ratio of active to total ERK. The anti-active antibody
First, the incubation period was lengthened from 30 to 120 min as recognizes the dually phosphorylated activated forms of ERK-1 and
pilot experiments with both cytosolic and membrane fractions ERK-2, whereas anti-ERK recognizes all forms of ERK-1 and
indicated that four times more reaction product was obtained with a ERK-2. A donkey anti-rabbit secondary antibody coupled to horse-
120-min incubation compared to 30 min. Second, an additional radish peroxidase was utilized to visualize protein bands by chemi-
wash step was added prior to the ®nal elution of phosphopeptide luminescence using Hyper ®lm ECL (Amersham, Buckinghamshire,
with formic acid to reduce background absorbance at 570 nm. UK). Film images were quanti®ed by using a scanning densito-
Aliquots (10 mL) of PC12 cell membranes or cytosol were incu- meter (United States Biochemical, Cleveland, OH, USA). Results
bated 120 min at 378C in a total volume of 25 mL of assay were expressed as a ratio of arbitrary density times area units
buffer containing 5 mm rhodamine-chomagranin substrate, 20 mm between anti-active and anti-ERK blots and then normalized to
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
4. 934 L. Edwards et al.
vehicle-treated controls run in parallel. Because identical results Results
were obtained for ERK-1 and -2, the data presented here represent
the combined ERK-1 and -2 bands.
Effect of moxonidine and phorbol myristate acetate on
the activity of three PKC isoforms
We ®rst determined whether the selected PKC isoforms
Assay of c-jun kinase activity
Assay of immunoprecipitated c-jun kinase (JNK) was conducted as could be detected in PC12 cells using dye-coupled chromo-
previously described (Coroneos et al. 1996). Cell lysates were granin substrate. The absolute activities for cPKCbII in
immunoprecipitated with rabbit polyclonal IgG directed against untreated control PC12 cells were: cytosol 1.2 ^ 0.2, and
JNK overnight at 48C, and the resulting immunocomplexes were membrane 0.86 ^ 0.1 mg of phosphorylated substrate per
captured with goat anti-rabbit IgG agarose for 8 h at 48C. The ¯ask. For nPKC absolute activities were: cytosol 0.59 ^ 0.1,
agarose complexes were collected by centrifugation and washed and membrane 1.0 ^ 0.1 mg per ¯ask. The activity of aPKCz
twice with PBS. The pellets were then incubated at 378C for 20 min was: cytosol 0.72 ^ 0.1, and membrane 1.0 ^ 0.2 mg of
with 1 mg rat c-jun, 3 mL ATP (cold, ®nal concentrated 25 mm), phosphorylated substrate per ¯ask. Thus, membrane-bound
1 mL [32P]ATP (speci®c activity . 4500 Ci/mmol) in a kinase PKC activity was comparable for the three isoforms, in
buffer (25 mL) as previously described (Coroneos et al. 1996). The
agreement with previous reports (Wooten et al. 1994).
samples were then boiled with Laemmli buffer for 2 min followed
The effect on PKC activity of treatment with either
by SDS±PAGE. After transfer to nitrocellulose, the blots were
exposed to Kodak OMAT ®lm for 24 h at 2808C. Protein bands moxonidine or phorbol myristate acetate is shown in Fig. 1.
were quanti®ed by scanning densitometry as described for ERK. Data are expressed as a net increase above untreated control
values determined in parallel. In response to 10 min of
treatment with 1.0 mm moxonidine, immunoprecipitated
Cell proliferation assays cPKCbII showed increased activity in solubilized membrane
Cell proliferation was measured by using the Cell Titer system ( p , 0.05, paired t-test), whereas cytosolic activity was
(Promega; Madison, WI, USA) as speci®ed in the manufacturers unchanged (Fig. 1). Treatment with 200 nm phorbol myri-
instructions. PC12 cells were plated at one-quarter of their normal state acetate for 10 min induced a nearly identical response.
density in 96-well plates in low-serum medium (1% horse serum In contrast, nPKC showed no signi®cant response to either
and 0.5% fetal calf serum). Cells were treated with increasing doses treatment in membrane or cytosolic fractions. The activity of
of clonidine or with 0.1% DMSO vehicle for 48 h. The number of the atypical isoform, aPKC1 showed translocation from the
viable cells was estimated by incubating the cells for 2 h at 37 8C cytosol to the membrane, as indicated by a decrease in the
with the metabolic dye [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
former and an increase in the latter (both p , 0.05, paired
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] inner salt (MTS;
t-test). As expected, there was no in¯uence of phorbol
Owen's reagent) (Cory et al. 1991). Metabolically oxidized
formazan product was read from an absorbance plate reader at
myristate acetate on the activity of aPKCz, a DAG-
490 nm, with the absorbance in cell-free control wells subtracted. insensitive isoform.
Results were expressed as corrected absorbance relative to vehicle-
treated controls run on the same plate.
Pilot experiments indicated that moxonidine had signi®cant
Effect of moxonidine on ERK activation in extracts from
proliferative action only when added every 12 h, consistent with differentiated PC12 cells
the short half life of this compound in vivo (Ernsberger et al. 1993). The activation of ERK-1 and ERK-2 was determined as the
Clonidine, an analog with similar I1-imidazoline receptor af®nity, ratio of the amount of dually phosphorylated active form to
was found to be effective when added once for up to 48 h, so total ERK immunoreactivity. A representative blot is shown
subsequent experiments were carried out with clonidine. This agent in Fig. 2, illustrating the time course of the response to
has a greater activity at a1- and a2-adrenergic receptors than 100 nm moxonidine. An increase in the amount of immuno-
moxonidine, but this was not thought relevant because PC12 cells reactivity to the anti-active antibody is apparent at the later
lack both a1- and a2-adrenergic receptors (Jinsi-Parimoo and Deth time points. The lower blot shows that the amount of ERK-2
1997; Berts et al. 1999). Indeed, PC12 cells have been used for
immunoreactivity was constant between lanes, indicating
transfection studies of these receptors speci®cally because they lack
equal loading. Mean data from four experiments showed
endogenous expression.
that moxonidine treatment of PC12 cells increased ERK
activation by about 160% relative to vehicle-treated controls
(Fig. 3). Signi®cant activation of ERK ( p , 0.05 Newman±
Data analysis
Keuls test) was detected at 30 min, and the peak activation of
Statistical comparisons were performed by t-test for two groups or
analysis of variance for multiple comparisons, with Newman± ERK occurred at 90 min, with a decline towards baseline
Keuls post hoc tests. Dose±responses data were ®tted to logistic after 2 h.
equations (Motulsky and Ransnas 1987) using the Prism data The dose-dependence for the action of moxonidine on
analysis package (GraphPad software, San Diego, CA, USA) to ERK is illustrated in Fig. 4. The immunoreactivity to the
obtain EC50 values. anti-active antibody increased with the concentration of
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
5. I1-Imidazoline, PKC and MAPK 935
Fig. 3 Time course of ERK and JNK activation in PC12 cells follow-
ing moxonidine (100 nM) treatment. The relative activation of ERK-1
and ERK-2 is de®ned by the ratio of total enzyme to the dually phos-
phorylated form, as illustrated in Fig. 2. JNK activity was measured
as immunoprecipitated kinase activity. For both kinases, the data
were expressed relative to vehicle treated controls run in parallel.
Data are presented as mean percentage change ^ SE from four
separate experiments run in duplicate.
moxonidine tested, whereas the total amount of ERK-2
protein was constant. Summary data from four separate
experiments show that moxonidine's effect on ERK was
dose-dependent up to 100 nm, with an EC50 of 1.3 nm
Fig. 1 Activity of PKC isoforms in fractions from PC12 cells treated (Fig. 5). A higher concentration of moxonidine, 1.0 mm,
with moxonidine or phorbol myristate acetate. Shown are relative activated ERK to a lesser extent than 100 nm. Comparable
rates of dye-labeled substrate phosphorylation activity of immuno- biphasic dose±response relationships have been reported for
precipitated PKC isoforms. Three representative PKC isozymes DAG accumulation (Separovic et al. 1996).
expressed in PC12 cells were isolated: cPKCbII, nPKC1, and
In order to test whether the effect of moxonidine on ERK
aPKCz. The effects of phorbol myristate acetate and moxonidine are
stimulation was mediated by the I1-imidazoline receptor and
represented by their percentage change ^ SE relative to controls
run in parallel in the same experiment. Data represent the
through its known transmembrane signaling pathways, we
mean ^ SE from 12 75-cm2 ¯asks of cells. Asterisks mark statisti- treated the cells with efaroxan, a selective I1-imidazoline
cally signi®cant increases ( p , 0.05, paired t-test). receptor antagonist, or with D609, an inhibitor of phospha-
tidylcholine-selective phospholipase C and I1-imidazoline
receptor signaling in PC12 cells (Fig. 6). Efaroxan (10 mm)
abolished ERK activation by 100 nm moxonidine treatment,
but had no signi®cant effect when given alone. The PC-PLC
inhibitor D609 (1.0 mm) also effectively abolished the effect
of moxonidine.
Fig. 2 Western blot illustrating the time course of ERK-2 activation
by moxonidine. The band labeled `phospho-ERK-2 MAPK' was from
a blot labeled with anti-active ERK antibody. The band labeled `pan-
ERK-2 MAPK' was stained for total ERK immunoreactivity. Each
lane was obtained from different ¯asks of PC12 cells incubated with Fig. 4 Western blot illustrating the dose-dependence of ERK-2 acti-
100 nM moxonidine for increasing amounts of time. Data were ana- vation by moxonidine. Bands are labeled as in Fig. 2. Each lane was
lyzed by determining the ratio of optical density between the ®rst obtained from different ¯asks of PC12 cells incubated with increas-
and second blot. ing concentrations of moxonidine for 90 min.
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
6. 936 L. Edwards et al.
Fig. 5 Dose dependence of the activation of ERK by moxonidine
treatment. PC12 cells were treated with increasing concentrations of
moxonidine for 90 min and then analyzed for total and activated
ERK as illustrated in Fig. 4. Data are presented as mean percentage
Fig. 7 Western blot showing abrogation of the ERK activation
change ^ SE from four separate experiments run in duplicate.
response to moxonidine by PKC depletion or inhibition. Bands are
labeled as in Fig. 2. Each lane was obtained from different ¯asks of
We next sought to test whether the activation of ERK PC12 cells incubated with various for 20 h or 90 min prior to har-
was mediated through PKC (Figs 7 and 8). Treatment with vesting. First and last lanes are from vehicle-treated control cells.
The second lane shows the response to 100 nM moxonidine relative
the non-selective PKC inhibitor H-7 [1-(5-isoquinoline-
to the vehicle control lane. The third lane is from a ¯ask of PC12
sulfonyl)-2-methylpiperazine] blocked the action of moxon-
cells that was processed in parallel but was pretreated with 200 nM
idine. Treatment with H-7 alone had no effect on ERK phorbol-12-myristate-13-acetate overnight to deplete PKC. The fourth
activation. In order to down-regulate DAG-sensitive iso- lane shows the response to short-term treatment with phorbol ester.
forms of PKC, we pretreated PC12 cells with 200 nm The ®fth lane shows that results treatment with the PKC inhibitor
phorbol myristate acetate for 20 h prior to exposure to H-7 during the 10 min pre-incubation and during moxonidine treat-
either phorbol or moxonidine for 90 min. Depletion of PKC ment, while the next lane illustrates the lack of effect of H-7 alone.
by prolonged treatment with phorbol myristate acetate The seventh lane shows that the response to phorbol ester is lost
abolished the response to short-term phorbol, con®rming after 20 h exposure to 200 nM phorbol-12-myristate-13-acetate.
that the prolonged treatment eliminated responsiveness of
ERK to PKC. In this series of experiments, treatment
with 200 nm moxonidine for 90 min roughly tripled the proportion of ERK in the active dually phosphorylated state
(Fig. 8). This action of moxonidine was eliminated by
depletion of PKC by chronic treatment with phorbol
myristate acetate.
We next sought to determine whether another I1-imidazo-
line agonist, clonidine, would elicit similar effects as moxo-
nidine. Flasks of PC12 cells were treated in parallel for
90 min with 100 nm moxonidine, 100 nm clonidine, or
vehicle. The ratio of activated ERK was 272 ^ 36% of
control in cells treated with moxonidine and 273 ^ 35% of
control in cells treated with clonidine. Thus, moxonidine
and clonidine induced similar activation of ERK, consistent
with their similar binding af®nities for the I1-imidazoline
receptor in PC12 cells (Separovic et al. 1996).
Fig. 6 Effects of a receptor blocker and an enzyme inhibitor on
ERK activation. PC12 cells were incubated with or without moxoni-
dine (100 nM) in the presence or absence of the I1-imidazoline
Effect of moxonidine on JNK activity in PC12 cell
antagonist efaroxan (10 mM) or the PC-PLC inhibitor D609 (10 mM)
extracts
for 90 min. Efaroxan or D609 were also present during a 10-min
In addition to the ERKs, an independently regulated
pre-incubation. ERK activation was then determined as described
above. Values are expressed as a percentage of vehicle treated
kinase cascade in PC12 cells involves JNKs. Moxonidine
controls. Each value represents the mean ^ SE of at least nine dose-dependently increased cellular activity of JNK up to
separate experiments. The effect of moxonidine alone was signi®- two-fold (Fig. 9). Peak effects were observed at 300 nm
cant ( p , 0.01, paired t-test) but no other treatment or combination moxonidine. In the presence of 10 mm efaroxan, 100 nm
of treatments had any signi®cant effect ( p . 0.10, paired t-test). moxonidine did not increase JNK activity (data not shown).
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
7. I1-Imidazoline, PKC and MAPK 937
Fig. 10 Concentration-dependent increase in PC12 cell proliferation
Fig. 8 Effects of PKC depletion or inhibition on ERK activation by
by clonidine. PC12 cells were grown in low-serum medium in the
moxonidine. PC12 cells were incubated with vehicle alone, moxoni-
presence of increasing concentrations of clonidine for 48 h, and then
dine (100 nM) alone, moxonidine in the presence of the PKC inhibitor
the density of viable metabolically active cells was determined by
H-7 (1.0 mM), H-7 alone, moxonidine following overnight exposure to
using the MTT metabolic dye. Values are expressed as a percen-
200 nM phorbol-12-myristate-13-acetate in order to deplete PKC, or
tage of vehicle treated controls. Each value represents the mean ^
the response to short-term treatment with phorbol ester with and
SEM of 18 separate wells.
without overnight exposure to phorbol-12-myristate-13-acetate. ERK
activation was determined as described above. Values are
expressed as a percentage of vehicle treated controls. Each value
Proliferative response of PC12 cells to imidazoline
represents the mean ^ SE of at least six separate experiments. The
agonists
effect of moxonidine alone and phorbol-12-myristate-13-acetate
alone were signi®cant ( p , 0.01, paired t-test), but no other treat-
The activity of ERK and possibly JNK as well is linked to
ment or combination of treatments had any signi®cant effect cell proliferation, particularly in transformed cell lines such
( p . 0.10, paired t-test). as PC12 cells (Cowley et al. 1994). Therefore, we tested the
effect of an I1-imidazoline receptor agonist on PC12 cell
number during 2 day treatment (Fig. 10). We used clonidine
The time course of JNK activation is indicated in Fig. 3 rather than moxonidine because of its longer metabolic half-
(squares). The increase in JNK activity tended to parallel life in vivo (Ernsberger et al. 1993) and because these two
the activation of ERK, with both peaking around 90 min I1-agonists showed similar activation of ERK (see above).
and declining by 120 min. The increase in JNK activity PC12 cells were seeded at one-fourth normal density in 96
was evident earlier, and reached signi®cance at 15 min well plates in low-serum medium in order to reduce
( p , 0.05, Newman±Keuls' test), whereas ERK was not background levels of proliferation. The ®nal number of
increased until 30 min of moxonidine treatment. viable PC12 cells after 2 days of treatment, as determined
with a metabolic dye, was increased by about 20% at the
lowest dose tested (0.1 nm), and by 50% at the highest
dose (1.0 mm), as shown in Fig. 10. Thus, stimulation of
I1-imidazoline receptors appears to induce a small but
consistent increase in PC12 cell number, suggesting an
increase in the number of proliferating cells.
Discussion
The present study identi®es several downstream cell
signaling events that are coupled to the stimulation of
I1-imidazoline receptors in PC12 rat pheochromocytoma
Fig. 9 Concentration-dependent stimulation of JNK activity by
cells. A common and an atypical isoform of PKC each
moxonidine. PC12 cells were incubated with or without varying showed increased enzymatic activity (cPKCbII and aPKCz),
doses of moxonidine (0.1 nM21 mM) or vehicle for 90 min and then whereas nPKC1 was not affected. The stimulation of
lysates were assayed for JNK phosphorylation. Each value repre- cPKCbII by the I1-imidazoline agonist moxonidine was
sents the mean ^ SEM of at least four experiments. comparable to that induced by treatment with a phorbol
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
8. 938 L. Edwards et al.
ester. In addition, aPKCz showed clear subcellular relocal- nearly 125% upon exposure to moxonidine. The possible
ization, with activity in the cytosol decreasing and that in the modulation of PC12 cell neuronal differentiation by
membrane fraction increasing. Two members of the MAPK I1-imidazoline receptors remains to be determined.
family of kinase cascades were also activated in response to Cellular DAG are known to regulate the activity of
moxonidine: ERK and JNK. These kinases showed roughly cPKCbII. Stimulation of I1-imidazoline receptors in PC12
parallel activation with a peak effect occurring around cells with moxonidine elevates total cellular mass of DAG
90 min of treatment. In PC12 cells stimulated with the (Separovic et al. 1996). Moreover, in the present study, the
I1-imidazoline agonist moxonidine, the proportion of ERK effects of moxonidine closely resembled those of phorbol
in its active dually phosphorylated form was increased ester, a diglyceride analog. Thus, the activation of cPKCbII
150%, whereas JNK activity was elevated nearly two-fold. by moxonidine might plausibly be the result of increased
The activation of both kinases was dose-dependent, and diglyceride levels. The mechanisms behind the activation of
in the case of ERK the EC50 for moxonidine was in aPKCz are not as clear. Arachidonic acid activates atypical
close agreement with the binding af®nity of the drug PKC isoforms in isolated brain membranes (Huang et al.
for I1-imidazoline receptors [Ki ˆ 7.8 nm; (Separovic et al. 1993).
1996)]. Finally, a modest but concentration-dependent The ERK family of MAPK were also activated in
increase in cell number was elicited by 2-day treatment of response to I1-imidazoline receptor stimulation. The MAPK
PC12 cell cultures with the I1-imidazoline agonist clonidine. family members, including ERK and JNK, typically mediate
This result implies a weak mitogenic action of I1-imidazo- responses to mitogenic stimuli and promote cell prolifera-
line receptors, consistent with their apparent activation of tion (Marshall 1995). Sustained activation of the MAPK
MAPK cascades. signaling pathway is reportedly both necessary and suf®-
In the present study, the activation of ERK was apparently cient to induce neuronal differentiation of PC12 cells
receptor-mediated, because it could be blocked by cotreat- (Cowley et al. 1994). We have reported a two-fold increase
ment with the I1-imidazoline antagonist efaroxan. Moreover, in ERK-activation by the I1-imidazoline agonists moxon-
the concentration range wherein moxonidine was effective idine and clonidine which can be blocked by efaroxan, an
in activating ERK and JNK was consistent with its binding I1-imidazoline receptor antagonist, and by D609, an inhibi-
af®nity for I1-imidazoline receptors, and the dose±response tor of PC-PLC. These data imply that activation of MAPK is
curves for ERK and JNK activation closely resembled pre- receptor-mediated and is downstream from phospholipid
viously reported dose±response relationships for I1-imidazo- hydrolysis pathways associated with the I1-imidazoline
line receptor activation of arachidonic acid release (Ernsberger receptor. Efaroxan can also acts as an a2-adrenergic antag-
1998), prostaglandin production (Ernsberger et al. 1995), onist in some cells in the dose range used in the present
and DAG accumulation (Separovic et al. 1996). study, but these receptors are not present in PC12 cells.
The I1-imidazoline receptor has been previously shown to Efaroxan has negligible af®nity for the mitochondrial
be coupled to activation of PC-PLC in PC12 cells, which I2-imidazoline subtype (Lione et al. 1996) which are present
leads to formation of DAG from phosphatidylcholine and an in these cells. The activation of ERK and JNK by moxo-
increased total cellular mass of this second messenger nidine was not sustained, but rather peaked around 90 min
(Separovic et al. 1996). We therefore hypothesized that PKC and declined substantially within 120 min. This pattern
may be activated by I1-imidazoline receptor stimulation. resembles the response to epidermal growth factor and other
The PKC multigene family of enzymes is involved in the agonists that activate ERK in PC12 cells, but stands in
control of many biological events and is a major transducer contrast to NGF-activation of ERK, which is sustained for
of receptor-mediated stimuli. In PC12 cells the I1-imidazo- many hours (Marshall 1995).
line receptor agonist moxonidine has been shown to activate The activation of ERK in response to imidazoline agonists
at least two isoforms of PKC (cPKCbII and aPKCz). PC12 appears to be downstream of PKC activation. Thus, deple-
cells are known to express the following PKC isotypes: a, tion of classical and novel isoforms of PKC by prolonged
bI, bII, d, 1, h and z (Hundle et al. 1995) and differentiation exposure to a phorbol ester blocked the response to moxon-
of PC12 cells to a neuronal phenotype by treatment with idine. Furthermore, a non-selective PKC inhibitor blocked
NGF induces increased expression of bII, d, and z, and the the response to moxonidine as well. These results implicate
appearance of PKC 1 and h within the nucleus (Borgatti the stimulation of PKC in the activation of ERK by
et al. 1996). This suggests that the I1-imidazoline receptor imidazoline agonists. The subtype of PKC responsible may
might modulate cell proliferation or neuronal differentiation be the bII isoform, as this form was activated in response
through activation of key PKC isoforms. In addition, the to moxonidine. While the aPKCz isoform was also
atypical z-PKC is required for neuronal differentiation activated, this atypical subtype of PKC is not known to
and neurite outgrowth of PC12 cells in response to NGF be depleted by prolonged stimulation with phorbol esters.
(Coleman and Wooten 1994), and thus the activity of this The isoform may participate in other downstream signaling
isoform in PC12 cell membrane fractions was increased by events.
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
9. I1-Imidazoline, PKC and MAPK 939
In the present study, a small but persistent and dose- of MAP kinase kinase is necessary and suf®cient for PC12
dependent increase in the number of viable cells was differentiation and for transformation of NIH 3T3 cells. Cell 77,
841±852.
noted in cultures of serum-starved PC12 cells treated with
Eglen R. M., Hudson A. L., Kendall D. A., Nutt D. J., Morgan N. G.,
I1-imidazoline agonist clonidine. An increase in total cell Wilson V. G. and Dillon M. P. (1998) `Seeing through a glass
number is a strong indicator that increased cell proliferation darkly': casting light on imidazoline `I' sites. Trends Pharmacol.
has occurred, although the number of actively dividing cells Sci. 19, 381±390.
was not measured. The activation of MAPK cascades may Ernsberger P. (1998) Arachidonic acid release from PC12 pheochromo-
cytoma cells is regulated by I1-imidazoline receptors. J. Auton.
have been too transient to induce a dramatic proliferative
Nerv. Syst. 72, 147±154.
response. The mitogenic effect was not altered when serum Ernsberger P. (1999) The I1-imidazoline receptor and its cellular
levels in the media were increased or the initial seeding signaling pathways. Ann. NY Acad. Sci. 881, 35±53.
density of the cells were changed systematically (data not Ernsberger P. and Haxhiu M. A. (1997) The I1-imidazoline-binding site
shown), implying that the effect of clonidine was not is a functional receptor mediating vasodepression via the ventral
strongly dependent upon culture conditions. medulla. Am. J. Physiol. 273, R1572±R1579.
Ernsberger P., Meeley M. P., Mann J. J. and Reis D. J. (1987) Clonidine
In conclusion, we have extended our model of the signal-
binds to imidazole binding sites as well as a2-adrenoceptors in the
ing pathway for I1-imidazoline receptor in PC12 cells to ventrolateral medulla. Eur. J. Pharmacol. 134, 1±13.
include coupling to PKC and MAPK. One possible function Ernsberger P., Elliott H. L., Weimann H.-J., Raap A., Haxhiu M. A.,
of these intermediates may be in promoting cell proliferation È È
Hofferber E., Low-Kroger A., Reid J. L. and Mest H.-J. (1993)
or possibly the modulation of neuronal differentiation. Moxonidine: a second-generation central antihypertensive agent.
Cardiovasc. Drug Rev. 11, 411±431.
Ernsberger P., Graves M. E., Graff L. M., Zakieh N., Nguyen P., Collins
Acknowledgements L. A., Westbrooks K. L. and Johnson G. G. (1995) I1-imidazoline
receptors: De®nition, characterization, distribution and transmem-
This work was supported by HL44514 (to PE and MK) and brane signaling. Ann. NY Acad. Sci. 763, 22±42.
DK53715 (to MK) from the National Institutes of Health. We Ernsberger P., Friedman J. E. and Koletsky R. J. (1997) The
acknowledge the technical assistance of Kathryn Zalovcik, BS I1-imidazoline receptor: from binding site to therapeutic target
and David Bedol, BS. in cardiovascular disease. J. Hypertens. 15, S9±S23.
Ho J. L., Zhu B., He S., Du B. and Rothman R. (1994) Interleukin 4
receptor signaling in human monocytes and U937 cells involves
References the activation of a phosphatidylcholine-speci®c phospholipase C:
a comparison with chemotactic peptide, FMLP, phospholipase D,
Berts A., Zhong H. and Minneman K. P. (1999) No role for Ca11 or and sphingomyelinase. J. Exp. Med. 180, 1457±1469.
protein kinase C in alpha-1A adrenergic receptor activation of Huang X. P., Da Silva C., Fan X. T. and Castagna M. (1993)
mitogen-activated protein kinase pathways in transfected PC12 Characteristics of arachidonic-acid-mediated brain protein kinase
cells. Mol. Pharmacol. 55, 296±303. C activation: Evidence for concentration-dependent heterogeneity.
Borgatti P., Mazzoni M., Carini C., Neri L. M., Marchisio M., Bertolaso Biochim. Biophys. Acta Mol. Cell Res. 1175, 351±356.
L., Previati M., Zauli G. and Capitani S. (1996) Changes of Hundle B., McMahon T., Dadgar J. and Messing R. O. (1995) Over-
nuclear protein kinase C activity and isotype composition in PC12 expression of epsilon-protein kinase C enhances nerve growth
cell proliferation and differentiation. Exp. Cell Res. 224, 72±78. factor-induced phosphorylation of mitogen-activated protein
Bousquet P., Feldman J., Bloch R. and Schwartz J. (1984) Central kinases and neurite outgrowth. J. Biol. Chem. 270, 30134±30140.
cardiovascular effects of a-adrenergic drugs: Differences between Jinsi-Parimoo A. and Deth R. C. (1997) Reconstitution of alpha2D-
catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230, adrenergic receptor coupling to phospholipase D in a PC12 cell
232±236. lysate. J. Biol. Chem. 272, 14556±14561.
Campbell W. R. and Potter D. E. (1994) Potential role of imidazoline Kobayashi H., Honma S., Nakahata N. and Ohizumi Y. (2000)
(I1) receptors in modulating aqueous humor dynamics. J. Ocul. Involvement of phosphatidylcholine-speci®c phospholipase C in
Pharmacol. 10, 393±402. thromboxane A2-induced activation of mitogen-activated protein
Cobb R. R., Felts K. A., Parry G. C. and Mackman N. (1996) D609, a kinase in astrocytoma cells. J. Neurochem. 74, 2167±2173.
phosphatidylcholine-speci®c phospholipase C inhibitor, blocks Limon-Boulez I., Tesson F., Gargalidis-Moudanos C. and Parini A.
interleukin-1 beta-induced vascular cell adhesion molecule 1 gene (1996) I2-imidazoline binding sites: relationship with different
expression in human endothelial cells. Mol. Pharmacol. 49, monoamine oxidase domains and identi®cation of histidine
998±1004. residues mediating ligand binding regulation by H11. J. Pharma-
Coleman E. S. and Wooten M. W. (1994) Nerve growth factor-induced col. Exp. Ther. 276, 359±364.
differentiation of PC12 cells employs the PMA-insensitive protein Lione L. A., Nutt D. J. and Hudson A. L. (1996) [3H]2-(2-
kinase C-zeta isoform. J. Mol. Neurosci. 5, 39±57. benzofuranyl)-2-imidazoline: a new selective high af®nity radio-
Coroneos E., Wang Y., Panuska J. R., Templeton D. J. and Kester M. ligand for the study of rabbit brain imidazoline I2 receptors. Eur. J.
(1996) Sphingolipid metabolites differentially regulate extra- Pharmacol. 304, 221±229.
cellular signal- regulated kinase and stress-activated protein Liu W. S. and Heckman C. A. (1998) The sevenfold way of PKC
kinase cascades. Biochem. J. 316, 13±17. regulation. Cell Signal. 10, 529±542.
Cory A. H., Owen T. C., Barltrop J. A. and Cory J. G. (1991) Use of an Mandal A., Wang Y., Ernsberger P. and Kester M. (1997) Interleukin-1-
aqueous soluble tetrazolium/formazan assay for cell growth assays induced ether-linked diglycerides inhibit calcium- insensitive
in culture. Cancer Commun. 3, 207±212. protein kinase C isotypes. Implications for growth senescence.
Cowley S., Paterson H., Kemp P. and Marshall C. J. (1994) Activation J. Biol. Chem. 272, 20306±20311.
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940
10. 940 L. Edwards et al.
Marshall C. J. (1995) Speci®city of receptor tyrosine kinase signaling: Activation of phosphatidylcholine-selective phospholipase C by
transient versus sustained extracellular signal-regulated kinase I1-imidazoline receptors in PC12 cells and rostral ventrolateral
activation. Cell 80, 179±185. medulla. Brain Res. 749, 335±339.
Motulsky H. J. and Ransnas L. A. (1987) Fitting curves to data using Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H.,
nonlinear regression: a practical and nonmathematical review. Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J. and
FASEB J. 1, 365±374. Klenk D. C. (1985) Measurement of protein using bicinchoninic
Piletz J. E., Ivanov T. R., Sharp J. D., Ernsberger P., Chang C. H., acid. Anal. Biochem. 150, 76±85.
Pickard R. T., Gold G., Roth B., Zhu H., Jones J. C., Baldwin J. Smyth D. D. and Penner S. B. (1999) Peripheral and central imidazoline
and Reis D. J. (2000) Imidazoline receptor antisera-selected receptor-mediated natriuresis in the rat. Ann. NY Acad. Sci. 881,
(IRAS) cDNA: cloning and characterization. DNA Cell Biol. 19, 344±357.
319±329. Toomik R., Ekman P., Eller M., Jarv J., Zaitsev D., Myasoedov N.,
Regunathan S. and Reis D. J. (1996) Imidazoline receptors and their Ragnarsson U. and Engstrom L. (1993) Protein kinase assay using
endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 36, 511±544. tritiated peptide substrates and ferric adsorbent paper for
Separovic D., Kester M. and Ernsberger P. (1996) Coupling of I1- phosphopeptide binding. Anal. Biochem. 209, 348±353.
imidazoline receptors to diacylglyceride accumulation in PC12 Wooten M. W., Zhou G., Seibenhener M. L. and Coleman E. S. (1994)
rat pheochromocytoma cells. Mol. Pharmacol. 49, 668±675. A role for zeta protein kinase C in nerve growth factor-induced
Separovic D., Kester M., Haxhiu M. A. and Ernsberger P. (1997) differentiation of PC12 cells. Cell Growth Differ. 5, 395±403.
q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 79, 931±940